OT-730 FDA Approval Status
FDA Approved: No
Brand name: OT-730
Company: Othera Pharmaceuticals, Inc.
Treatment for: Glaucoma
OT-730 is an oculoselective beta-blocker under review as a potential treatment for glaucoma.
Development timeline for OT-730
| Date | Article |
|---|---|
| Aug 7, 2008 | Othera Files IND Application for OT-730 in Glaucoma |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
